UBR5 Targets Tumor Suppressor CDC73 Proteolytically to Promote Aggressive Breast Cancer

Researchers demonstrated that CDC73 was a key substrate that impeded ubiquitin protein ligase E3 component n-recognin 5 (UBR5)’s profound tumorigenic and metastatic activities in TNBC.